Search research articles
Contact Us
Filters
Showing results (61-70 of 171) with videos related to
Page
of 18
Sort By:
Journal of Virology
|
October 1, 1984
Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis
T B Sculley, P J Walker, D J Moss, et al.
Mutation Research
|
September 1, 1989
Solar and UVC-induced mutation in human cells and inhibition by deoxynucleosides
P Musk, R Campbell, J Staples, et al.
Clinical and Experimental Immunology
|
April 1, 1985
T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines
C J Bishop, D J Moss, J M Ryan, et al.
Clinical and Experimental Immunology
|
April 1, 1985
T lymphocytes in infectious mononucleosis. I. T cell death in vitro
D J Moss, C J Bishop, S R Burrows, et al.
Nature
|
June 25, 1981
Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation
D J Moss, A B Rickinson, L E Wallace, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 21, 2001
The immunology of Epstein-Barr virus infection
D J Moss, S R Burrows, S L Silins, et al.
The Journal of Infectious Diseases
|
September 1, 1990
Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects
T B Sculley, A Apolloni, L Hurren, et al.
International Immunology
|
February 27, 2001
Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters
M Sherritt, L Cooper, D J Moss, et al.
Journal of Neurochemistry
|
March 1, 1990
Chicken growth-associated protein GAP-43 is tightly bound to the actin-rich neuronal membrane skeleton
D J Moss, P Fernyhough, K Chapman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 3, 1999
Developing immunotherapeutic strategies for the control of Epstein-Barr virus-associated malignancies
D J Moss, R Khanna, M Sherritt, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 171) with videos related to
Sort By:
Page
of 18
Journal of Virology
|
October 1, 1984
Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis
T B Sculley, P J Walker, D J Moss, et al.
Mutation Research
|
September 1, 1989
Solar and UVC-induced mutation in human cells and inhibition by deoxynucleosides
P Musk, R Campbell, J Staples, et al.
Clinical and Experimental Immunology
|
April 1, 1985
T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines
C J Bishop, D J Moss, J M Ryan, et al.
Clinical and Experimental Immunology
|
April 1, 1985
T lymphocytes in infectious mononucleosis. I. T cell death in vitro
D J Moss, C J Bishop, S R Burrows, et al.
Nature
|
June 25, 1981
Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation
D J Moss, A B Rickinson, L E Wallace, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 21, 2001
The immunology of Epstein-Barr virus infection
D J Moss, S R Burrows, S L Silins, et al.
The Journal of Infectious Diseases
|
September 1, 1990
Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects
T B Sculley, A Apolloni, L Hurren, et al.
International Immunology
|
February 27, 2001
Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters
M Sherritt, L Cooper, D J Moss, et al.
Journal of Neurochemistry
|
March 1, 1990
Chicken growth-associated protein GAP-43 is tightly bound to the actin-rich neuronal membrane skeleton
D J Moss, P Fernyhough, K Chapman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 3, 1999
Developing immunotherapeutic strategies for the control of Epstein-Barr virus-associated malignancies
D J Moss, R Khanna, M Sherritt, et al.
Page
of 18